MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck
about
DNA methylation and microRNA dysregulation in cancerThe Roles of Two miRNAs in Regulating the Immune Response of Sea CucumberMicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivoMiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cellsMiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas.Methylation-mediated molecular dysregulation in clinical oral malignancyEpigenetic dysregulation in laryngeal squamous cell carcinoma.The role of microRNAs expression in laryngeal cancerIdentification of an epigenetic profile classifier that is associated with survival in head and neck cancer.MicroRNAs in Head and Neck CancerGenomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cellsMecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met.Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.MicroRNAs in an oral cancer context - from basic biology to clinical utility.Current trends in miRNAs and their relationship with oral squamous cell carcinoma.Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.Role of miRNA in head and neck squamous cell carcinoma.Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.MiR-137: an important player in neural development and neoplastic transformation.MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L.Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients.MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma.Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop.miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS.A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.Epigenetics and MicroRNAs in Cancer.High glucose suppresses the viability and proliferation of HTR‑8/SVneo cells through regulation of the miR‑137/PRKAA1/IL‑6 axis.Gga-miR-130b-3p inhibits MSB1 cell proliferation, migration, invasion, and its downregulation in MD tumor is attributed to hypermethylation.
P2860
Q26998741-8DF0515B-E50C-4528-AB51-05C63828D293Q30380229-BA87E00E-5F83-428E-97CD-B4431962D5CEQ34087915-08C9035C-47C4-4E68-BE73-BB10EAA7DFC6Q34104157-75E98086-9522-4E11-9226-2BE6033B5882Q34306332-C41A9BA7-D1F0-4497-98C9-5071DBDDF6D1Q34314172-039C991D-149C-4B29-ABE0-4E7313EDB2FEQ34497810-D54FD0DB-EDA7-4159-8329-3A1645D90833Q35170951-A73580EB-2C3F-40CB-A785-319D68E36BF2Q35952029-6730E058-D3B0-4A50-B80F-77926AAF8857Q35974424-4C59C849-FB01-4FED-B0D3-42B342B0FDD5Q35974482-E4E6EAFD-3AB5-44BC-B920-9C43D50BC7A7Q36414172-83F48757-055B-4590-9DE7-88EFD94E8863Q36833387-DE3D7CEF-C4C6-4413-8D85-7C51497CCA54Q37292279-3B1522AC-98D1-4C6D-B314-4ABC528D9214Q37505070-48D666F8-14C4-4F41-A561-AE5330CE3DC4Q37536706-35D778D6-90EB-4F45-AEE6-5E90C0ECE98FQ37581142-AE744148-4BB8-4272-8F64-A5DBF670FD1EQ37698759-C614FFC4-E4A8-4CB0-9FCD-B9F2FFB03707Q37718295-E1034DFF-FAF4-4308-AA42-426460C8C57BQ37968114-879D201E-A850-4AF4-9B3E-CBF75C9D3D77Q37970449-5D7D9BF8-9924-44DB-A3F4-5E86532FCD41Q37973293-81B48F6F-235A-4E41-8B10-ABAE03946186Q38174477-37BD27B3-2F5B-4352-A9C5-7901616D3D2FQ38264776-6BF2F4AF-4A4B-49AE-B2E1-37EC4DEC4962Q38664137-8F06495C-B783-40D9-92D3-AD8357B9E737Q38749382-A0BDC71B-A5EF-4153-A2ED-4D2A46FA87BFQ38885469-D9F74780-FA27-4B2C-A1F5-014256C1F653Q38952716-8E6943E5-CC4F-4243-80EC-5D33C7AA4305Q39223766-31DB3F68-953C-48D0-93F1-86B3761881A4Q39517680-5400742C-42DE-42D5-8160-353A7CC43847Q40517870-63269C2C-D707-49FD-BDD4-7546E45DEF03Q41974346-51A87457-D01F-4045-B019-1286D3442EFDQ42123071-7A2547C2-2B5E-43F1-B2C8-1E80BDA73E0FQ43413469-A8C6EC6A-21B6-43AE-858D-2AF254590959Q45960821-478F7FB6-F32C-4F58-A4C5-810614B6E75CQ49874571-C70D873D-156F-43F1-85BB-FE8A9D5924AAQ50015658-43F62717-107E-4837-95F3-2B3387686306Q51770872-920CD178-EABD-436E-BE2B-7F90D9DB92B9Q54108131-944EAF61-A8C5-4EA2-AB8B-ED4B89F29B0EQ55112818-E9A31D1D-ABDE-441F-A2BA-5D7D58C4ADB3
P2860
MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MicroRNA-137 promoter methylat ...... carcinoma of the head and neck
@ast
MicroRNA-137 promoter methylat ...... carcinoma of the head and neck
@en
type
label
MicroRNA-137 promoter methylat ...... carcinoma of the head and neck
@ast
MicroRNA-137 promoter methylat ...... carcinoma of the head and neck
@en
prefLabel
MicroRNA-137 promoter methylat ...... carcinoma of the head and neck
@ast
MicroRNA-137 promoter methylat ...... carcinoma of the head and neck
@en
P2093
P2860
P356
P1433
P1476
MicroRNA-137 promoter methylat ...... carcinoma of the head and neck
@en
P2093
Clareann H Bunker
Emanuela Taioli
Lori Kelly
Maureen A Lyons-Weiler
Raja R Seethala
Robert W Sobol
Roslyn A Stone
William A LaFramboise
P2860
P304
P356
10.1002/CNCR.25689
P407
P577
2010-11-08T00:00:00Z